By Ria Kakkad (Drug Target Review)2023-03-09T11:48:14
Lipid nanoparticles have been used to encapsulate CRISPR-Cas9 and deliver it to cells in mice, where it was highly effective at knocking down expression of a target protein.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-03-03T14:06:14
Sponsored by Bio-Techne
2023-01-06T16:37:30
Sponsored by Catalent
2023-03-23T14:46:21
Sponsored by Bio-Techne
2025-05-14T14:30:00
Sponsored by Abzena
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
Site powered by Webvision Cloud